FormWeb • Hazardous Drugs

Oregon Department of Corrections

Approved Formulary

Webpage Links

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Hazardous Drugs

Please review each of these drugs carefully.

abacavir	Handling Guide (Group 2: Non-Antineoplastic)
abacavir-lamiVUDine	Handling Guide (Group 2: Non-Antineoplastic)
abacavir/dolutegravir/lamiVUDine	Handling Guide (Group 2: Non-Antineoplastic)
abacavir/lamiVUDine/zidovudine	Handling Guide (Group 2: Non-Antineoplastic)
abiraterone	Handling Guide (Group 1: Antineoplastic)
acitretin	Handling Guide (Group 3: Reproductive Risk)
anastrazole	Handling Guide (Group 1: Antineoplastic)
azaTHIOprine	Handling Guide (Group 2: Non-Antineoplastic)
bicalutamide	Handling Guide (Group 1: Antineoplastic)
cabergoline	Handling Guide (Group 3: Reproductive Hazard)
capecitabine	Handling Guide (Group 1: Antineoplastic)
carBAMazepine	Handling Guide (Group 2: Non-Antineoplastic)
clonazepam	Handling Guide (Group 3: Reproductive Risk)
colchicine	Handling Guide (Group 3: Reproductive Hazard)
conjugated estrogens	Handling Guide (Group 2: Non-Antineoplastic)
cyclophosphamide	Handling Guide (Group 1: Antineoplastic)
cycloSPORINE	Handling Guide (Group 2: Non-Antineoplastic)
cyclosporine injectable	Handling Guide (Group 2: Non-Antineoplastic)
cycloSPORINE ophthalmic	Handling Guide (Group 2: Non-Antineoplastic)
dabrafenib	Handling Guide (Group 1: Antineoplastic)
degarelix	Handling Guide (Group 1: Antineoplastic)
divalproex sodium	Handling Guide (Group 2: Non-Antineoplastic)
drospirenone-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
dutasteride	Handling Guide (Group 3: Reproductive Risk)
entecavir	Handling Guide (Group 2: Non-Antineoplastic)
enzalutamide	Handling Guide (Group 1: Antineoplastic)
estradiol	Handling Guide (Group 2: Non-Antineoplastic)
estradiol injectable	Handling Guide (Group 2: Non-Antineoplastic)
etonogestrel-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
finasteride	Handling Guide (Group 3: Reproductive Risk)
fluconazole	Handling Guide (Group 3: Reproductive Risk)
fluorouracil topical	Handling Guide (Group 1: Antineoplastic)
ganciclovir ophthalmic	Handling Guide (Group 2: Non-Antineoplastic)
hydroxyurea	Handling Guide (Group 1: Antineoplastic)
interferon alfa-2b-ribavirin	Handling Guide (Group 3: Reproductive Risk)
leflunomide	Handling Guide (Group 2: Non-Antineoplastic)
lenalidomide	Handling Guide (Group 2: Non-Antineoplastic)
lenvatinib	Handling Guide (Group 1: Antineoplastic)
leuprolide	Handling Guide (Group 1: Antineoplastic)
levonorgestrel-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
liraglutide	Handling Guide (Group 2: Non-Antineoplastic)
medroxyPROGESTERone	Handling Guide (Group 2: Non-Antineoplastic)
megestrol	Handling Guide (Group 1: Antineoplastic)
mercaptopurine	Handling Guide (Group 1: Antineoplastic)
methimazole	Handling Guide (Group 2: Non-Antineoplastic)
methotrexate	Handling Guide (Group 1: Antineoplastic)
methylergonovine	Handling Guide (Group 3: Reproductive Risk)
miSOPROStol	Handling Guide (Group 3: Reproductive Risk)
mycophenolate mofetil	Handling Guide (Group 2: Non-Antineoplastic)
nevirapine	Handling Guide (Group 2: Non-Antineoplastic)
norelgestromin-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
norethindrone	Handling Guide (Group 2: Non-Antineoplastic)
norethindrone-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
norethindrone-ethinyl estradiol-fe	Handling Guide (Group 2: Non-Antineoplastic)
norgestimate-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
norgestrel-ethinyl estradiol	Handling Guide (Group 2: Non-Antineoplastic)
OXcarbazepine	Handling Guide (Group 2: Non-Antineoplastic)
palifermin
PARoxetine	Handling Guide (Group 3: Reproductive Risk)
phenytoin	Handling Guide (Group 2: Non-Antineoplastic)
progesterone	Handling Guide (Group 2: Non-Antineoplastic)
ribavirin	Handling Guide (Group 3: Reproductive Risk)
SORAfenib	Handling Guide (Group 1: Antineoplastic)
spironolactone	Handling Guide (Group 2: Non-Antineoplastic)
tacrolimus	Handling Guide (Group 2: Non-Antineoplastic)
tacrolimus topical	Handling Guide (Group 2: Non-Antineoplastic)
tamoxifen	Handling Guide (Group 1: Antineoplastic)
temazepam	Handling Guide (Group 3: Reproductive Risk)
temozolomide	Handling Guide (Group 1: Antineoplastic)
testosterone	Handling Guide (Group 3: Reproductive Risk)
tofacitinib	Handling Guide (Group 2: Non-Antineoplastics)
topiramate	Handling Guide (Group 3: Reproductive Hazard)
trametinib	Handling Guide (Group 1: Antineoplastic)
tretinoin	Handling Guide (Group 1: Antineoplastic)
tretinoin topical	Handling Guide (Group 3: Reproductive Risk)
valproic acid	Handling Guide (Group 3: Reproductive Risk)
voriconazole	Handling Guide (Group 3: Reproductive Hazard)
warfarin	Handling Guide (Group 3: Reproductive Risk)
zidovudine	Handling Guide (Group 2: Non-Antineoplastic)
ziprasidone	Handling Guide (Group 3: Reproductive Risk)
zoledronic acid	Handling Guide (Group 3: Reproductive Hazard)
zonisamide	Handling Guide (Group 3: Reproductive Risk)

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.